ATCT-12RESULTS OF NRG ONCOLOGY/RTOG 9813- A PHASE III RANDOMIZED STUDY OF RADIATION THERAPY (RT) AND TEMOZOLOMIDE (TMZ) VERSUS RT AND NITROSOUREA (NU) THERAPY FOR ANAPLASTIC ASTROCYTOMA (AA) Article

Chang, Susan, Zhang, Peixin, Cairncross, J Gregory et al. (2015). ATCT-12RESULTS OF NRG ONCOLOGY/RTOG 9813- A PHASE III RANDOMIZED STUDY OF RADIATION THERAPY (RT) AND TEMOZOLOMIDE (TMZ) VERSUS RT AND NITROSOUREA (NU) THERAPY FOR ANAPLASTIC ASTROCYTOMA (AA) . NEURO-ONCOLOGY, 17(suppl_5), v3-v3. 10.1093/neuonc/nov206.12

cited authors

  • Chang, Susan; Zhang, Peixin; Cairncross, J Gregory; Gilbert, Mark R; Bahary, Jean Paul; Dolinskas, Carol; Aldape, Kenneth D; Bell, Erica; Sciff, David; Jaeckle, Kurt; Brown, Paul D; Barger, Geoffrey R; Werner-Wasik, Maria; Shih, Helen; Brachman, David; Prado, Marta Penas; Robins, H Ian; Belanger, Karl; Schultz, Christopher J; Chakravarti, Arnab; Mehta, Minesh

authors

publication date

  • November 1, 2015

published in

keywords

  • 32 Biomedical and Clinical Sciences
  • 3211 Oncology and Carcinogenesis
  • Brain Cancer
  • Brain Disorders
  • Cancer
  • Clinical Research
  • Clinical Trials and Supportive Activities
  • Radiation Oncology
  • Rare Diseases

Digital Object Identifier (DOI)

publisher

  • Oxford University Press (OUP)

start page

  • v3

end page

  • v3

volume

  • 17

issue

  • suppl_5